A randomized, multicenter, multinational, phase 3B, open-label, parallel-group study of agalsidase beta in treatment-naive male pediatric patients with Fabry disease without severe symptoms: Baseline demographics and clinical data

✍ Scribed by Wijburg, Frits; Bénichou, Bernard; Bichet, Daniel G.; Dostalova, Gabriela; Clarke, Lorne; Fainboim, Alejandro; Fellgiebel, Andreas; Forcelini, Cassiano; Haack, Kristina An; Hopkin, Robert; Scott, C. Ronald; Shankar, Suma; Tylki-Szymanska, Anna; Tøndel, Camilla; Ramaswami, Uma

• Book ID: 121949235
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 67 KB
• Volume: 108
• Category: Article
• ISSN: 1096-7192
• DOI: 10.1016/j.ymgme.2012.11.272